4/A//SEC Filing
KURLAND FRED 4/A
Accession 0001104659-18-072488
CIK 0001614067other
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 11:39 AM ET
Size
5.5 KB
Accession
0001104659-18-072488
Insider Transaction Report
Form 4/AAmended
KURLAND FRED
Chief Financial Officer
Transactions
- Award
Stock Options
2018-12-05+17,000→ 39,574 totalExercise: $8.50Exp: 2028-12-05→ Common Stock (17,000 underlying)
Footnotes (2)
- [F1]The shares underlying this stock option vest as follows: in equal annual installments over the 48 months following the date of grant.
- [F2]Due to a clerical error, the reporting person is filing this Amendment to correct the amount of derivative securities beneficially owned following the reported transaction from 40,024 to 39,574.
Documents
Issuer
Aridis Pharmaceuticals, Inc.
CIK 0001614067
Entity typeother
Related Parties
1- filerCIK 0001267273
Filing Metadata
- Form type
- 4/A
- Filed
- Dec 11, 7:00 PM ET
- Accepted
- Dec 12, 11:39 AM ET
- Size
- 5.5 KB